Production Linked Incentive (PLI) schemes for bulk drugs and medical devices received 247 and 28 applications, respectively, so far, an official statement said on Friday.
The schemes, which close on November 30, will select a maximum of 136 applications for (bulk drugs) and 28 for medical devices respectively. IFCI Ltd is the project management agency for both the schemes, the statement said.
Though the schemes were announced in March this year, the guidelines for implementation were issued initially in September. But guidelines were further refined on October 29 on the basis of feedback received from the industry.
Both the PLI schemes are aimed at enhancing indigenous production of critical drugs and medical devices so that the country could be self-reliant.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.